Parameters | EOC and stages | Borderline | Adenoma | ||||
---|---|---|---|---|---|---|---|
Total | I | II | III | IV | |||
N | 146 | 29 | 10 | 35 | 15 | 19 | 83 |
Age at diagnosis (mean ± SD) | 54.67 ± 13.84* | 47.96 ± 11.54 | 51.6 ± 12.5 | 58.9 ± 14.4 | 60.3 ± 11.2 | 46.15 ± 11.15 | 42.01 ± 15.06 |
30 or less | 8 (5.5%) | 3 (10.3%) | 1 (10,0%) | 2 (5.7%) | 0 (0.0%) | 2 (10.5%) | 21 (25.3%) |
31 to 40 | 11 (7.5%) | 3 (10.3%) | 1 (10,0%) | 1 (2.9%) | 0 (0.0%) | 4 (21.1%) | 19 (22.9%) |
41 to 50 | 42 (28.8%) | 12 (31.4%) | 2 (20,0%) | 13 (37.1%) | 4 (2.7%) | 7 (36.8%) | 13 (15.7%) |
51 to 60 | 32 (21.9%) | 5 (17.2%) | 4 (40,0%) | 3 (8.6%) | 4 (2.7%) | 3 (15.8%) | 15 (18.0%) |
Over 60 | 52 (35.6%) | 4 (13.8%) | 2 (20,0%) | 16 (45.7%) | 7 (46.7%) | 3 (15.8%) | 12 (14.5%) |
Missing data | 1 (0.7%) | 0 (0.0%) | 0 (0,0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 3 (3.6%) |